Overview

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Status:
Unknown status

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

Recently studies have shown that intravitreal injection of ranibizumab is effective for age related macular degeneration. However there are problems about injection regimen of maintenance phase. We plan to perform new simplified treat and extend regimen using ranibizumab.

Phase:

N/A

Details

Lead Sponsor:

Mie University

Treatments:

Ranibizumab